Beyond survival: Multisystem long-term outcomes following HSCT in chronic granulomatous disease
Authors:
- Valentina GuarnieriVGValentina Guarnieri
- Jesmeen MaimarisJMJesmeen Maimaris
- Sohilla LotfySLSohilla Lotfy
- Elizabeth RiversERElizabeth Rivers
- Stuart AdamsSAStuart Adams
- Kimberly GilmourKGKimberly Gilmour
- Andrea MeinhardtAMAndrea Meinhardt
- Arnold AwuahAAArnold Awuah
- Mercedes SelbyMSMercedes Selby
- Daisy ShillingfordDSDaisy Shillingford
- Emma GravettEGEmma Gravett
- Susanne Kricke OrszulikSOSusanne Kricke Orszulik
Open Access
- 6 February 2026
- journal article
- Published by Rockefeller University Press in Journal of Human Immunity
- Vol. 2 (2)
Abstract
Data on late complications after hematopoietic stem cell transplantation (HSCT) in children with chronic granulomatous disease (CGD) are limited. We retrospectively analyzed 42 pediatric CGD patients who survived >2 years post-HSCT (1994–2020) at Great Ormond Street Hospital. X-linked CGD accounted for 69%. Pre-HSCT comorbidities included lung disease (48%), colitis/fistulizing disease (45%), and liver abscesses (19%). Median HSCT age was 6 years. 10-year overall survival was 95.2%, and event-free survival (events: death, second intervention) was 81%. 13 (33%) cases developed autoimmunity (AI); eight had relapsing or late-onset (>2 years) AI. Organ-specific late effects included lung abnormalities (n = 7), liver dysfunction (n = 7), renal disease (n = 3), and recurrent/new-onset colitis (n = 3). Endocrine sequelae comprised obesity (n = 15), gonadal dysfunction (n = 9), and short stature (n = 7). Skeletal (n = 6), neurological (n = 6), psychological (n = 19), visual (n = 5), and hearing impairments (n = 4) were noted. Late malignancy was reported in two cases. HSCT offers excellent long-term survival in CGD, but significant late effects underscore the need for extended multidisciplinary follow-up.Keywords
This publication has 42 references indexed in Scilit:
- Non-osteopenic Bone Pathology After Allo-hematopoietic Stem Cell Transplantation in Patients with Inborn Errors of ImmunityJournal of Clinical Immunology, 2023
- The effect of HLA matching and donor relatedness on the risk of autoimmune haemolytic anaemia in haematopoietic stem cell transplant recipients: A systematic review and meta‐analysiseJHaem, 2022
- Retrospective, Landmark Analysis of Long-term Adult Morbidity Following Allogeneic HSCT for Inborn Errors of Immunity in Infancy and ChildhoodJournal of Clinical Immunology, 2022
- Outcome of Non-hematological Autoimmunity After Hematopoietic Cell Transplantation in Children with Primary ImmunodeficiencyJournal of Clinical Immunology, 2020
- Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCTJournal of Clinical Immunology, 2019
- Health Related Quality of Life and Emotional Health in Children with Chronic Granulomatous Disease: A Comparison of Those Managed Conservatively with Those That Have Undergone Haematopoietic Stem Cell TransplantJournal of Clinical Immunology, 2012
- Inflammatory Manifestations in Chronic Granulomatous Disease (CGD)Journal of Clinical Immunology, 2008
- Autosomal recessive chronic granulomatous disease caused by novel mutations in NCF-2 , the gene encoding the p67- phox component of phagocyte NADPH oxidaseHuman Genetics, 1999
- Pericardial effusions in two boys with chronic granulomatous diseasePediatric Radiology, 1999
- Chronic graft-versus-host syndrome in manThe American Journal of Medicine, 1980